Metformin as a Weight-Loss Tool in "At-Risk" Obese Adolescents: A Magic Bullet?

Journal of Pediatrics

Volumn 152, Issue 6, 2008, Pages 750-752

  Kasa Vubu, Josephine Z ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN;

BODY MASS; CALORIC INTAKE; CHILDHOOD; CLINICAL TRIAL; DISEASE PREDISPOSITION; EDITORIAL; EPIDEMIC; ETHNICITY; GLUCOSE METABOLISM; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; PUBERTY; RISK FACTOR; SITTING; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADOLESCENT; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; OBESITY; RISK FACTORS;

EID: 43549089486     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.03.006     Document Type: Editorial

References (33)

1. Metzger B.E. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50 (2007) 972-979
2. Bouhours-Nouet N., Dufresne S., de Casson F.B., Mathieu E., Douay O., Gatelais F., et al. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?. Diabetes Care (2008) In press
3. Watkins M.G., Clark K.M., Foster C.M., Welch K.B., and Kasa-Vubu J.Z. Relationships among body mass index, parental perceptions, birthweight and parental weight after referral to a weight clinic. J Natl Med Assoc 99 (2007) 908-913
4. de Zegher F., and Ibanez L. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril 86 Suppl 1 (2006) S4-S5
5. Vuguin P., Grinstein G., Freeman K., Saenger P., and DiMartino Nardi J. Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR score. Horm Res 65 (2006) 185-191
6. Lumeng J.C., Appugliese D., Cabral H.J., Bradley R.H., and Zuckerman B. Neighborhood safety and overweight status in children. Arch Pediatr Adolesc Med 160 (2006) 25-31
7. Sallis J.F., and Glanz K. The role of built environments in physical activity, eating, and obesity in childhood. Future Child 16 (2006) 89-108
8. Taylor R.W., McAuley K.A., Williams S.M., Barbezat W., Nielsen G., and Mann J.I. Reducing weight gain in children through enhancing physical activity and nutrition: the APPLE project. Int J Pediatr Obes 1 (2006) 146-152
9. Levine J.A. Nonexercise activity thermogenesis-liberating the life-force. J Intern Med 262 (2007) 273-287
10. Silverstein J., Klingensmith G., Copeland K., Plotnick L., Kaufman F., Laffel L., et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28 (2005) 186-212
11. Kasa-Vubu J.Z., Lee C.C., Rosenthal A., Singer K., and Halter J.B. Cardiovascular fitness and exercise as determinants of insulin resistance in postpubertal adolescent females. J Clin Endocrinol Metab 90 (2005) 849-854 Epub 2004 Nov 30
12. Maffeis C., Banzato C., and Talamini G. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 152 (2008) 207-213
13. Harris M.I., Klein R., Welborn T.A., and Knuiman M.W. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15 (1992) 815-819
14. Saad R., Gungor N., and Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes 6 (2005) 95-99
15. Nguyen S., McCulloch C., Brakeman P., Portale A., and Hsu C.Y. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 121 (2008) 37-45
16. Kahn R. Metabolic syndrome: is it a syndrome?. Does it matter?. Circulation 115 (2007) 1806-1811
17. Goodman E., Daniels S.R., Meigs J.B., and Dolan L.M. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 115 (2007) 2316-2322
18. Yamada S., Tsukamoto Y., and Irie J. Waist circumference in metabolic syndrome. Lancet 370 (2007) 1541-1542
19. Zimmet P., Alberti G., Kaufman F., Tajima N., Silink M., Arslanian S., et al. The metabolic syndrome in children and adolescents. Lancet 369 (2007) 2059-2061
20. Weiss R., Taksali S.E., Tamborlane W.V., Burgert T.S., Savoye M., and Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28 (2005) 902-909
21. Gahagan S., and Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health. Pediatrics 112 (2003) e328
22. Goran M.I., Ball G.D., and Cruz M.L. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 88 (2003) 1417-1427
23. EndocrineSciences aEC. Expected values and S.I unit conversion tables. 3rd ed. (2003), Las Calabasa, California
24. Kruger J., Galuska D.A., Serdula M.K., and Jones D.A. Attempting to lose weight: specific practices among US adults. Am J Prev Med 26 (2004) 402-406
25. Ratner R.E. An update on the Diabetes Prevention Program. Endocr Pract 12 Suppl 1 (2006) 20-24
26. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., and Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 (2006) 289-297
27. Love-Osborne K., Sheeder J., and Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr 152 (2008) 817-822
28. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
29. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
30. McCartney C.R., Prendergast K.A., Chhabra S., Eagleson C.A., Yoo R., Chang R.J., et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab 91 (2006) 1714-1722 Epub 2006 Feb 21
31. Arslanian S.A., Lewy V., Danadian K., and Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 87 (2002) 1555-1559
32. Hoeger K.M., Kochman L., Wixom N., Craig K., Miller R.K., and Guzick D.S. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 82 (2004) 421-429
33. Kumanyika S.K. Special issues regarding obesity in minority populations. Ann Intern Med 119 (1993) 650-654